WMSA
GHDX

Weiss Multi-Strategy Advisers’s Genomic Health, Inc. GHDX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-12,430
Closed -$364K – 1182
2013
Q4 		$364K Buy
+12,430
New +$394K 0.01% 747

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ICM
IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return

Weiss Multi-Strategy Advisers's GHDX Position: Q1 2014 in Review

Weiss Multi-Strategy Advisers sold out of Genomic Health, Inc. (GHDX) in Q1 2014, closing a stake of 12,430 shares — an estimated $364K sold.

Weiss Multi-Strategy Advisers first reported a position in GHDX in Q4 2013 and held it in 1 quarter. The position peaked at $364K in Q4 2013. 101 funds tracked by Wall St. Rank hold GHDX as of Q1 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Genomic Health, Inc. position as of Q1 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 12,430 Genomic Health, Inc. shares in Q1 2014, an estimated $364K.
  • Weiss Multi-Strategy Advisers first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Genomic Health, Inc. position peaked at $364K in Q4 2013.
  • 101 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.